Veterinary Medicines

Salmoporc, lyophilisate and solvent for suspension for injection for pigs

Authorised
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, strain 421/125 (histidine-adenine auxotrohic), Live
Download as PDF

Product identification

Medicine name:
Salmoporc, liofilizado e solvente para suspensão injetável para suínos
Salmoporc, lyophilisate and solvent for suspension for injection for pigs
Active substance:
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, strain 421/125 (histidine-adenine auxotrohic), Live
Target species:
  • Pig
Route of administration:
  • Oral use
  • Subcutaneous use

Product details

Active substance and strength:
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, strain 421/125 (histidine-adenine auxotrohic), Live
    8.00
    log10 colony forming unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Withdrawal period by route of administration:
  • Oral use
    • Pig
      • Meat and offal
        6
        week
  • Subcutaneous use
    • Pig
      • Meat and offal
        6
        week
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AE02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:
  • Cardboard box containing 1 vial with 20 doses (1 dose = 1 ml) lyophilised vaccine
  • 1 vial with 20 ml solvent

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Similar biological application (Article 13(4) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Saude Animal Produtos Farmaceuticos E Imunologicos Lda.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva-Phylaxia Zrt.
  • IDT Biologika GmbH
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 966/01/19DIVPT
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0247/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Hungary
  • Ireland
  • Italy
  • Portugal
  • Romania
  • Slovakia
  • United Kingdom (Northern Ireland)